We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $289B
1-Year Est. Return 60.46%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
+60.46%
3 Year Est. Return
+148.24%
5 Year Est. Return
+163.86%
10 Year Est. Return
+570.16%
AUM
$56.3B
AUM Growth
+$6.14B
Cap. Flow
+$1.76B
Cap. Flow %
3.13%
Top 10 Hldgs %
15.08%
Holding
4,631
New
103
Increased
2,522
Reduced
1,306
Closed
116

Sector Composition

Rank Sector Weight
1 Technology 8.31%
2 Financials 6.96%
3 Consumer Discretionary 5.46%
4 Healthcare 4.97%
5 Industrials 4.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROX
3976
DELISTED
Castle Brands, Inc.
ROX
$12.5K ﹤0.01%
9,920
-491
-5% -$397
VIA
3977
DELISTED
Viacom Inc. Class A
VIA
$12.4K ﹤0.01%
474
+98
+26% +$3.05K
AUBN icon
3978
Auburn National Bancorp
AUBN
$92.4M
$12.4K ﹤0.01%
274
HBIO icon
3979
Harvard Bioscience
HBIO
$30.4M
$12.4K ﹤0.01%
403
DLTH icon
3980
Duluth Holdings
DLTH
$151M
$12.3K ﹤0.01%
1,450
+422
+41% +$4.62K
VATE icon
3981
INNOVATE Corp
VATE
$102M
$12.2K ﹤0.01%
517
LEGH icon
3982
Legacy Housing
LEGH
$692M
$12.1K ﹤0.01%
749
+81
+12% +$1.11K
MLP icon
3983
Maui Land & Pineapple Co
MLP
$310M
$12.1K ﹤0.01%
1,110
+244
+28% +$2.57K
CVIA
3984
DELISTED
Covia Holdings Corporation Common Stock
CVIA
$12K ﹤0.01%
5,920
-155
-3% -$288
MRNS
3985
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$11.9K ﹤0.01%
1,930
+611
+46% +$4.94K
SCOR icon
3986
Comscore
SCOR
$91.6M
$11.8K ﹤0.01%
309
+176
+132% +$10.2K
GEN
3987
DELISTED
Genesis Healthcare, Inc.
GEN
$11.8K ﹤0.01%
10,636
-914
-8% -$1.06K
CLVS
3988
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$11.8K ﹤0.01%
30
BWX icon
3989
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.31B
$11.7K ﹤0.01%
407
TCS
3990
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$11.7K ﹤0.01%
176
-95
-35% -$7.71K
GAIA icon
3991
Gaia
GAIA
$33.3M
$11.7K ﹤0.01%
1,783
-15
-0.8% -$106
ICBK
3992
DELISTED
County Bancorp, Inc. Common Stock
ICBK
$11.6K ﹤0.01%
593
SIEB icon
3993
Siebert Financial
SIEB
$78.1M
$11.6K ﹤0.01%
1,262
+354
+39% +$3.61K
STRO icon
3994
Sutro Biopharma
STRO
$353M
$11.6K ﹤0.01%
127
+9
+8% +$909
PRVL
3995
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$11.5K ﹤0.01%
+938
New +$10.6K
NATR icon
3996
Nature's Sunshine
NATR
$269M
$11.5K ﹤0.01%
1,388
+23
+2% +$210
ASX icon
3997
ASE Group
ASX
$103B
$11.4K ﹤0.01%
2,565
-1,661
-39% -$7.31K
ABEO icon
3998
Abeona Therapeutics
ABEO
$361M
$11.4K ﹤0.01%
202
+1
+0.5% +$75
LEAF
3999
DELISTED
Leaf Group Ltd.
LEAF
$11.4K ﹤0.01%
2,723
+651
+31% +$3.46K
MORF
4000
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$11.3K ﹤0.01%
+625
New +$13.1K

Similar funds

BNP Paribas Financial Markets's Q3 2019 Portfolio in Review

As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $235M trimmed.

  • BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
  • BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
  • BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
  • BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
  • BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
  • BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
  • BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.